1. Academic Validation
  2. A degron-mimicking molecular glue drives CRBN homo-dimerization and degradation

A degron-mimicking molecular glue drives CRBN homo-dimerization and degradation

  • Nat Commun. 2025 Nov 19;16(1):10157. doi: 10.1038/s41467-025-65094-3.
Gerasimos Langousis 1 Pablo Gainza 1 Moritz Hunkeler 2 Despoina Kapsitidou 1 Etienne J Donckele 1 Stefano Annunziato 1 Lars Wiedmer 1 Katherine F M Jones 1 Bradley DeMarco 1 Chao Quan 1 Richard D Bunker 1 Kevin J Lumb 1 Bernhard Fasching 1 John C Castle 1 Sharon A Townson 1 Débora Bonenfant 3
Affiliations

Affiliations

  • 1 Monte Rosa Therapeutics AG, Basel, Switzerland.
  • 2 University of Basel, BioEM Lab, Basel, Switzerland.
  • 3 Monte Rosa Therapeutics AG, Basel, Switzerland. [email protected].
Abstract

Cereblon (CRBN) is an E3 ubiquitin Ligase widely harnessed for targeted protein degradation (TPD). We report the discovery of a molecular glue degrader (MGD), MRT-31619, that drives homo-dimerization of CRBN and promotes its fast, potent, and selective degradation by the ubiquitin Proteasome system. Interestingly, the cryo-electron microscopy (cryo-EM) structure of the CRBN homodimer reveals a unique mechanism whereby two Molecular Glues assemble into a helix-like structure and drive ternary complex formation by mimicking a neosubstrate G-loop degron. This CRBN chemical knockout offers a valuable tool to elucidate the molecular mechanism of MGDs, to investigate its endogenous substrates and understand their physiological roles.

Figures
Products